Clinical Development

Aliona Tappert

Drug Safety Leader

Aliona Tappert is a physician specialized in General Medicine and Dermato-venerology. She had worked in different hospitals as medical practitioner before switching to Pharma. She has more than 10 years of cross-functional R&D experience in the pharmaceutical industry including Literature Review Expert/ Medical Evaluator, Clinical Trials Group Manager, Business Development- and Project Manager/ Clinical Trials Center. Aliona joined Merck KGaA Darmstadt, Germany, in October 2011 where she has been working since then as Global Drug Safety Product Leader, being accountable for all medical safety aspects of assigned medicinal products.

Amit Desai

Amit Desai joined Astellas Pharma in 2009 in the pharmacometrics groups, which is part of clinical pharmacology and exploratory development. At Astellas Pharma, Amit had worked on numerous projects in infectious disease, CNS and oncology therapeutic areas, both as a modeling and simulation lead and also as clinical pharmacology lead. Before joining Astellas Pharma, Amit worked in Abbott Laboratories in clinical pharmacology.  He has a Ph.D in pharmaceutical and chemical sciences from University of the Pacific, Stockton, CA.

Xiaoyan Yin

Senior Expert Biostatistician

Xiaoyan Yin joined EMD Serono (R&D center in the US for Merck KGaA, Germany) in June 2018. Xiaoyan obtained her PhD in biostatistics from Boston University in 2008, then worked at Veristat Inc. as a biostatistician before joining Framingham Heart Study, Boston University in 2010 as a research assistant professor. In 2016, she moved to pharmaceutical industry and worked at Celldex Therapeutics as a senior manager biostatistician leading on multiple oncology studies. Her research interest includes analysis of incomplete data and trajectory modeling of longitudinal data.   

Deon Bezuidenhout

Site relationship and operations lead

Deon Bezuidenhout has worked at the South African Affiliate of Merck KGaA,Darmstadt, Germany since 2013 and currently fulfills the positions of Site Relationship & Operations lead and Clinical Research Manager. Deon brings 10 years of experience in different positions in clinical trial management across a wide range of therapeutic areas, including Malaria and HIV/Aids. He has a Diploma Leading to Registration as a professional nurse.

Eliézer K. N'Goran

Prof. Dr. Eliézer K. N’Goran is from the Université Félix Houphouët Boigny-Abidjan in Côte d’Ivoire. He is currently the head of the department of Zoology and animal Biology and the unit of parasitology, and parasite ecology in the Biosciences faculty. Since the 1990 he activly pursue research, teaching and training. The main activities of his group are epidemiology, ecology, clinical research on drug effectiveness and efficiency and public health issues of human schistosomiasis and geohelminthiases, but also focusses on participating in clinical trials in Côte d’Ivoire. He has published more than 100 manuscripts, original articles and reviews on schistosomiasis research.

Eric Huber

Clinical Trial Management

Eric Huber is a Project Leader in the Pharmaceutical Medicines Unit at the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel, Switzerland. He leads the planning, organization, management & monitoring of trials, with a focus on neglected diseases. Through this work, he has gained extensive experience in the management of clinical phase I to IV vaccine and drug trials. In addition, he organizes and contributes to capacity building projects.

Maurice Odiere

Clinical trial PI, Kenya

Maurice Odiere joined the Kenya Medical Research Institute (KEMRI) as Research assistant in 2004. After obtaining his PhD in Parasitology in 2010, he worked as a Senior research officer at KEMRI for 6 years. As Principal Investigator and Co-Investigator, he gained extensive experience in running research studies on schistosomiasis and soil-transmitted helminthiases in western Kenya. He is currently a Principal Research Officer and Head, Neglected Tropical Diseases Unit at KEMRI’s Centre for Global Health Research in western Kenya. Research focus of his team include understanding disease transmission dynamics, burden and morbidity, immunity/resistance to infection, and operational research on best approaches to controlling schistosomiasis and evaluation of new diagnostic tools for program managers to use.

Wilma Bagchus

Global Early Development Lead (Clinical Pharmacology)

Wilma Bagchus currently works at the US affiliate of Merck KGaA, Darmstadt, Germany and was educated as a medical biologist, holding a PhD in medicine and registered as an Immunologist. She has 24 years of experience in drug development in the pharmaceutical industry starting in Research.  She held the last 15 years various positions as a Clinical Pharmacologist doing First in Men and Clinical Pharmacology trials for different development projects in various therapeutic areas.